Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Nova Pharmaceuticals Australasia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (335)
Cancellation by sponsor (106)
Cancellation or suspension (30)
Prescription medicine registration (20)
Listed medicine compliance report (3)
Cancellation for failure to pay annual charge (1)

Date

2026 (74)
2025 (59)
2024 (45)
2023 (28)
2022 (22)
2021 (26)
2020 (44)
2019 (28)
2018 (30)
2017 (49)
2016 (13)
2015 (7)
2014 (3)
2013 (12)
2012 (19)
2011 (9)
2010 (9)
2009 (4)
2008 (1)
2007 (6)
2006 (3)
2005 (2)
2004 (2)

Search

Sponsor content

495 result(s) found, displaying 51 to 60

Medix Lemon Lime Effervescent Electrolyte Tablets Cancelled under Section 30(1)(c) of the Act

27 June 2026

Cancellation by sponsor

Requested by Nova Pharmaceuticals Australasia Pty Ltd
Medix Strawberry Effervescent Electrolyte Tablets Cancelled under Section 30(1)(c) of the Act

27 June 2026

Cancellation by sponsor

Requested by Nova Pharmaceuticals Australasia Pty Ltd
Medix Orange Effervescent Electrolyte Tablets Cancelled under Section 30(1)(c) of the Act

27 June 2026

Cancellation by sponsor

Requested by Nova Pharmaceuticals Australasia Pty Ltd
MEDICHOICE OSTEO-CAPS paracetamol 665 mg modified release tablet bottle (525449)

10 April 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MEDICHOICE OSTEO-CAPS paracetamol 665 mg modified release tablet bottle.
FUDANTIN nitrofurantoin 50 mg capsule blister pack (486469)

9 April 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FUDANTIN nitrofurantoin 50 mg capsule blister pack.
FUDANTIN nitrofurantoin 100 mg capsule blister pack (486465)

9 April 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FUDANTIN nitrofurantoin 100 mg capsule blister pack.
NITRUVIA nitrofurantoin 50 mg capsule blister pack (486472)

9 April 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NITRUVIA nitrofurantoin 50 mg capsule blister pack.
NITRUVIA nitrofurantoin 100 mg capsule blister pack (486471)

9 April 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NITRUVIA nitrofurantoin 100 mg capsule blister pack.
AURIXIN HC (Nova Pharmaceuticals Australasia Pty Ltd)

18 June 2026

Prescription medicine registration

Active ingredients: ciprofloxacin hydrochloride, hydrocortisone.
RHEMIX (Nova Pharmaceuticals Australasia Pty Ltd)

16 June 2026

Prescription medicine registration

Active ingredients: Varenicline tartrate.

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.